BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Deals

  Chinese Tycoon Eyes $500M IPO of Luye Life Sciences’ Clinic Arm

  The company’s Luye Medical Group unit plans to evaluate proposals from investment banks as soon as next month, according to the people.

  January 24, 2018

   · 

  1 min read
• 

  Deals

  Flushed With Cash, Shanghai Pharma Hunts for M&A in the U.S. and Europe

  This acquisition strategy is part of its two-pronged approach to growth, along with internal R&D.

  January 24, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Why This Heart Drug Could Be a $5B Blockbuster for Novartis

  Entresto, introduced in 2015, got off to a slow start but brought in $507 million in revenue last year.

  January 24, 2018

   · 

  1 min read
• Business

  TxCell Announces 4th Quarter 2017 Financials and Participation at Upcoming Scientific Conferences

  TxCell today reports its fourth quarter 2017 financials and provides an update on its financing.

  January 24, 2018

   · 

  6 min read